» Articles » PMID: 9445908

[Risk Factors for Retinal Occlusive Diseases]

Overview
Publisher Thieme
Specialty Ophthalmology
Date 1998 Jan 31
PMID 9445908
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Retinal vascular occlusions are the second most common retinal vascular diseases following diabetic retinopathy. Central retinal artery occlusion and branch retinal artery occlusion are most often caused by emboli. The mean age of patients with retinal artery occlusion and branch retinal artery occlusion is 62 and 58 years, respectively. The most common risk factors are arterial hypertension (65%), diabetes mellitus (25%), valvular diseases of the heart (25%), and carotid artery stenosis or plaques (45%). Rare causes are arteritis and vascular spasm. The pathogenesis of retinal branch vein occlusion and central retinal vein occlusion remains speculative. Two different mechanisms have been postulated, i.e. thrombosis in the vein due to a compression by atherosclerotic changes in the adjacent artery and a local alteration of the blood flow due to unfavourable physiologic factors. Retinal vein occlusion manifests at a mean age of 65 years. The most common risk factors are arterial hypertension in 34-75% and primary open angle glaucoma in 2.1-82%. In 5.6% of the patients with retinal branch vein occlusion retinal vasculitis is present.

Citing Articles

Unilateral branch retinal artery occlusion in association with COVID-19: a case report.

Hirosawa K, Inomata T, Sung J, Morooka Y, Huang T, Akasaki Y Int J Ophthalmol. 2024; 17(4):777-782.

PMID: 38638251 PMC: 10988083. DOI: 10.18240/ijo.2024.04.25.


[Nonaretritic central retinal artery occlusion as marker for the generalized vascular risk].

Feltgen N, Liman J, Schultheiss M, Spitzer M, Pielen A, Poli S Ophthalmologe. 2021; 118(11):1093-1098.

PMID: 34350493 DOI: 10.1007/s00347-021-01466-6.


Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion.

Shahsuvaryan M Int J Ophthalmol. 2013; 5(6):759-70.

PMID: 23275914 PMC: 3530822. DOI: 10.3980/j.issn.2222-3959.2012.06.20.


Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 : EAGLE Study report no. 1.

Feltgen N, Neubauer A, Jurklies B, Schmoor C, Schmidt D, Wanke J Graefes Arch Clin Exp Ophthalmol. 2005; 244(8):950-6.

PMID: 16372192 DOI: 10.1007/s00417-005-0140-2.


[Occlusion of the retinal artery].

Feltgen N, Schmidt D, Hansen L Ophthalmologe. 2003; 100(8):651-65; quiz 666-7.

PMID: 12974235 DOI: 10.1007/s00347-003-0845-8.